Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Bioterrorism -- Ignore unavailable to you. Want to Upgrade?

To: pavlov2 who wrote (184)	10/10/2001 11:27:57 AM
From: BulbaMan	Read Replies (2) \| Respond to of 891

Daw Technologies (DAWK) could be another "non-pure" bioterrorism play. According to a company press release, it "specializes in the design, engineering and installation of cleanroom and mini-environment systems that meet stringent semiconductor and pharmaceutical manufacturing requirements." It would seem that bioterrorism research would require lots of new cleanrooms. Based on diluted shares, DAWK's market cap is a miniscule $7 million. Yet, they're a real company with $27.6 mil. in revenue for the first half and earnings $.05 per diluted share.